Press-release for stocks related to test for genetic technologies ltd

Prices are updated after-hours

tags : Test entities : Genetic technologies ltd

save search

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -8.61% | O: 1.12% H: 1.85% C: -5.19%
test risk advanced

Launching our most comprehensive test and expanding into new global markets
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 24.49% | O: 6.63% H: 0.0% C: -6.7%
test global

GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -10.95% | O: 1.09% H: 14.8% C: 12.56%
disease test saliva wellness

Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
Published: 2023-07-28 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 197.56% | O: 3.35% H: 0.0% C: -2.53%
test commercial growth

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer
Published: 2023-02-06 (Crawled : 14:20) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 44.38% | O: -0.59% H: 11.31% C: 5.36%
test breast genetic cancer risk

Back-to-back Studies Validate geneType Breast Cancer Risk Test
Published: 2023-03-13 (Crawled : 14:20) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 119.82% | O: 0.0% H: 6.31% C: 4.5%
test breast cancer risk

Publication Validates geneType Prostate Cancer Risk Test
Published: 2023-04-19 (Crawled : 14:00) - biospace.com/
GENE | News | $2.33 -4.51% 27K

Health Technology

| 119.82% | O: 3.6% H: 0.87% C: -1.74%
test cancer publication risk

GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
Published: 2023-03-27 (Crawled : 15:00) - biospace.com/
GENE | News | $2.33 -4.51% 27K

Health Technology

| 121.82% | O: -0.91% H: 8.26% C: 7.34%
test cancer pancreatic

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
Published: 2023-02-03 (Crawled : 15:00) - biospace.com/
GENE | News | $2.33 -4.51% 27K

Health Technology

| 141.58% | O: 67.33% H: 0.0% C: 0.0%
risk test breast cancer ovarian cancer

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
Published: 2022-09-29 (Crawled : 12:20) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 97.57% | O: 0.81% H: 0.44% C: -2.41%
risk test cancer publication

GeneType Risk Assessment Test onboarding in 16 clinics
Published: 2022-07-01 (Crawled : 12:20) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 110.34% | O: -0.86% H: 5.3% C: 5.22%
risk test

US Patent Office Grants Patent for COVID-19 Risk Test
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
GENE | News | $2.33 -4.51% 27K

Health Technology

| 27.75% | O: -2.62% H: 4.51% C: 2.69%
covid-19 risk patent covid test grant granted

GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia
Published: 2022-02-22 (Crawled : 19:00) - biospace.com/
GENE | News | $2.33 -4.51% 27K

Health Technology

| 21.39% | O: 3.48% H: 0.0% C: -8.17%
approval australia test commercialization

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO
Published: 2021-12-09 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| 12.44% | O: 9.68% H: 0.0% C: 0.0%
covid-19 partnership genetic risk patent allowance patent covid test

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities
Published: 2021-07-09 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -37.44% | O: 2.56% H: 0.0% C: -3.0%
genetic risk test cancer

Genetic Technologies’ COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX
Published: 2021-06-01 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -40.63% | O: -4.7% H: 4.93% C: -1.97%
covid partnership genetic risk test covid-19

Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release
Published: 2021-04-26 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -40.34% | O: 4.82% H: 1.24% C: -4.13%
covid genetic risk test technology approval covid-19 commercialization

Genetic Technologies Provides Update on COVID-19 Risk Test Launch
Published: 2021-04-09 (Crawled : 15:15) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -43.12% | O: 0.47% H: 33.18% C: 6.03%
covid genetic risk test technology covid-19

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
Published: 2021-01-21 (Crawled : 12:01) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology

| -43.26% | O: 76.74% H: 7.63% C: -27.89%
covid test disease risk expansion

COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory
Published: 2020-04-17 (Crawled : 22:17) - globenewswire.com
GENE | News | $2.33 -4.51% 27K

Health Technology